MMP Capital has become the gold standard in equipment financing. We’re proud to be at the forefront of our industry and are on track to finance over $400 million this calendar year.

A new research paper was published in Oncotarget, Volume 16, on February 28, 2025, titled “Effect of TIMPs and their minimally engineered variants in blocking invasion and migration of brain cancer ...

A new research paper was published in Oncotarget, Volume 16, on February 28, 2025, titled "Effect of TIMPs and their ...

The crystal structure of human matrix metalloproteinase type-2 (MMP-2), a key target for several anticancer therapies currently in trials, has now been solved to a 2.8Å resolution (Science 284 ...